Naoko Takebe to Histone-Lysine N-Methyltransferase
This is a "connection" page, showing publications Naoko Takebe has written about Histone-Lysine N-Methyltransferase.
Connection Strength
0.231
-
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 07 01; 4(7):1793-1801.
Score: 0.231
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.